Vanguard Personalized Indexing Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $730K | Buy |
3,023
+900
| +42% | +$217K | 0.01% | 1027 |
|
|
2025
Q1 | $517K | Sell |
2,123
-250
| -11% | -$60.9K | 0.01% | 1098 |
|
|
2024
Q4 | $780K | Buy |
2,373
+522
| +28% | +$171K | 0.01% | 897 |
|
|
2024
Q3 | $619K | Buy |
1,851
+120
| +7% | +$40.2K | 0.01% | 1003 |
|
|
2024
Q2 | $473K | Sell |
1,731
-152
| -8% | -$41.5K | 0.01% | 1068 |
|
|
2024
Q1 | $651K | Buy |
1,883
+305
| +19% | +$105K | 0.01% | 873 |
|
|
2023
Q4 | $510K | Buy |
1,578
+332
| +27% | +$107K | 0.01% | 991 |
|
|
2023
Q3 | $447K | Buy |
1,246
+55
| +5% | +$19.7K | 0.01% | 926 |
|
|
2023
Q2 | $452K | Sell |
1,191
-194
| -14% | -$73.5K | 0.01% | 936 |
|
|
2023
Q1 | $663K | Sell |
1,385
-150
| -10% | -$71.9K | 0.02% | 735 |
|
|
2022
Q4 | $645K | Buy |
1,535
+568
| +59% | +$239K | 0.03% | 697 |
|
|
2022
Q3 | $403K | Buy |
967
+349
| +56% | +$145K | 0.02% | 854 |
|
|
2022
Q2 | $306K | Sell |
618
-190
| -24% | -$94.1K | 0.01% | 981 |
|
|
2022
Q1 | $455K | Sell |
808
-44
| -5% | -$24.8K | 0.02% | 863 |
|
|
2021
Q4 | $644K | Buy |
852
+245
| +40% | +$185K | 0.04% | 599 |
|
|
2021
Q3 | $453K | Sell |
607
-45
| -7% | -$33.6K | 0.04% | 571 |
|
|
2021
Q2 | $420K | Buy |
652
+23
| +4% | +$14.8K | 0.04% | 568 |
|
|
2021
Q1 | $359K | Buy |
629
+268
| +74% | +$153K | 0.05% | 437 |
|
|
2020
Q4 | $210K | Buy |
+361
| New | +$210K | 0.05% | 491 |
|